How much will the Artificial Organ And Bionics industry be worth in the Future????
The global artificial
organ and bionics market
is expected to reach USD 38.75 billion
by 2020 at an estimated CAGR of 9.3%
from 2014 to 2020, according to a new study by Grand View Research, Inc.
Increasing prevalence of acute renal failure and renal disorders due to lifestyle
habits such as excessive alcohol consumption and growing geriatric population
base causing a rise in organ failure rates is expected to serve this market as
a high impact rendering driver. In addition, growing incidence rates of
accidents is expected to boost the demand for organ transplants, thus
increasing demand for artificial organ. Artificial kidney dominated the global
market in 2013, with revenue estimated at over USD 12.21 billion; demand is
expected grow due to the increasing chronic kidney patients. Artificial liver
is the fastest growing market.
Some of the key players of the artificial
organ or bionic implant market include Abiomed Inc., Asahi Kasei Kuraray
Medical Co. Ltd., Thoratec Corporation, WorldHeart Corp., Gambro AB, Biomet
Inc., Cochlear Ltd, Berlin Heart Gmbh, Ekso Bionics, Medtronic Inc., Lifenet
Health, Heartware International Inc. Jarvik Heart Inc. Walk Inc.Ossur, Boston
Scientific Corporation, Sorin S.P.A., and others.
An
artificial organ is a device which is man-made and is integrated or implanted
into the human in order to restore target function via the replacement of a
natural organ. The material used to develop body interfaces or implants are
known as biomaterials. Processing abilities that are not occurring naturally
can be constructed and installed with the help of artificial organs and
replaced function need not be in the context of life support but generally, it
is to support life. There is no necessity to bind artificial organ with
stationary sources and stationary power supply for example chemical processing
units and filters.
To Request Sample Copy of this report, click the link:
The
application and study of electronics and mechanics for replacing a limb or
mechanically powered part of a functional organ is termed as medical bionics.
Due to the rapid development in the field of biomedical science, organ
transplantation has evolved as a common practice. For humans, new organs can be
artificially grown in a lab known as in vitro, in vivo with the use of stem
cells, xenotransplantation or in genetically modified animal and cyborgisation
or built as a machine. Artificial organ market includes artificial ear, corpora
cavernosa, cardiac and pylorus valves, brain, eye, artificial limbs, heart,
bladder, pancreas, limbs, trachea, ovaries, ear, and others.
Further key findings from the study
suggest:
·
Brain bionics in the medical
bionics market held the largest share of revenue for the year 2013 and the
market is expected to grow at an estimated CAGR of 40.0%.The presence of high
unmet medical needs in neurology disease segment coupled with expensive
treatment procedures is expected to drive the market for brain bionics.
Exoskeleton is the fastest growing segment and is expected to grow at a CAGR of
16.0% from 2014 to 2020.
·
North America was the largest
regional market in 2013, accounting for over 42.0% of global revenue due to the
increasing population and awareness among the patients and the players.
·
Asia Pacific is the fastest
growing market and is expected to grow at a CAGR of 11.0% from 2014 to 2020 on
account of rising demand due to the improvement in healthcare facilities,
medical tourism and others.Increasing income levels and healthcare expenditure
is expected to interest of the players’ in the emerging markets.
·
Key industry participants
include Abiomed Inc., Asahi Kasei Kuraray Medical Co. Ltd., Thoratec
Corporation, WorldHeart Corp., Gambro AB and others.
All
artificial organs do not repair physical damage such as a brain pacemaker that
helps in relieving epilepsy, neural network diseases and shivering of
Parkinson’s disease. In spite of being expensive artificial organs are
constructed and installed to support life and for the prevention of imminent
death while waiting for a transplant, cosmetic restoration after accident and
others. Research is in the process in the areas of information processing,
memory, and vision. Researchers are currently working to make the bionic organs
more permanent and are also commissioning on natural and sensory feel of the
devices so that they may replicate original organs and instruments such as 3D
printing of bionic organs, another type of organ such as artificial skin and
others are expected to emerge in the coming future. There is the development of
bionic orthopedics, bionic eye and exoskeleton only in specific regions because
of more research in some regions as compared to others. Increase in prevalence
of renal disorders and acute renal failure due to the faulty lifestyle of the
general population followed by increase in organ failure because of age-related
disorders and aging, increase in injuries and accidents which lead to
amputations and rise in number of people for organ transplants are the drivers
for the growth of the market.
Product Insights
Key product segments covered in this
report includes artificial organs such as total artificial heart, artificial
liver, artificial pancreas, artificial lungs, artificial kidney and bionics
such as cochlear implants, exoskeletons, cardiac bionics, bionic limbs, brain
bionics and vision bionics.
Technology Insights
Key technology segments of artificial
organ market are mechanical bionics and electronic bionics. There has been a
great advancement in artificial organic or bionic implant industry in the past
and because of the challenge of fulfilling unmet demands, the trend is expected
to further rise. The focus of manufactures is on the development of organs such
as bio-lung, wearable artificial kidney, and artificial pancreas.
Browse
Press Release of this report:
Grand View Research has segmented the
global artificial organ and bionics market on the basis of product, technology
and region:
Artificial Organ Product Outlook
·
Artificial organs
o Total artificial heart
o Artificial liver
o Artificial pancreas
o Artificial lungs
o Artificial kidney
·
Bionics
o Cochlear implants
o Exoskeletons
o Cardiac bionics
o Heart valves
o Biological tissue valves
o Mechanical valves
o Transcatheter heart valves
o Ventricular assist device
·
Bionic limbs
o Bionic legs
o Bionic hands
·
Brain bionics
o Deep brain stimulators
o Spinal cord stimulators
o Vagus nerves stimulators
·
Vision bionics
Artificial Organ Technology Outlook
·
Mechanical bionics
·
Electronic bionics
Artificial Organ Regional Outlook
·
North America
·
Europe
·
Asia Pacific
·
RoW
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment